N. Rioux-Leclercq

发表

Characterization of renal tumours based on Raman spectra classification

Lotfi Senhadji, Renaud de Crevoisier, Julien Fleureau, 2011, Expert Syst. Appl..

External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2021, European urology open science.

Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading

B. Delahunt, H. Samaratunga, J. Srigley, 2017, Histopathology.

Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2017, Targeted Oncology.

Unusual Morphologic Patterns of Basal Cell Hyperplasia of the Prostate

N. Rioux-Leclercq, J. Epstein, 2002, The American journal of surgical pathology.

Safety and Efficacy of Sorafenib in Renal Cell Carcinoma

K. Bensalah, N. Rioux-Leclercq, C. Vigneau, 2012 .

Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2017, The Journal of urology.

Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy

N. Rioux-Leclercq, J. Bernhard, G. Pagès, 2021, BJU international.

[Clamping modalities during partial nephrectomy: technical aspects and functional consequences. Review by the Comité de cancérologie de l'Association française d'urologie (CCAFU)].

N. Rioux-Leclercq, J. Patard, L. Salomon, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Optical spectroscopy techniques can accurately distinguish benign and malignant renal tumours

Lotfi Senhadji, Karim Bensalah, Olivier Lavastre, 2013, BJU international.

Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.

N. Rioux-Leclercq, K. Leong, B. Malavaud, 2004, The Journal of urology.

Laparoscopic partial nephrectomy with clamping of the renal parenchyma: initial experience.

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2007, European urology.

Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data.

N. Rioux-Leclercq, W. Hilgers, P. Barthélémy, 2021, Cancer treatment reviews.

RBM10‐TFE3 fusions: A FISH‐concealed anomaly in adult renal cell carcinomas displaying a variety of morphological and genomic features: Comprehensive study of six novel cases

N. Rioux-Leclercq, M. Sibony, V. Molinie, 2021, Genes, chromosomes & cancer.

All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.

N. Rioux-Leclercq, J. Goujon, C. Vigneau, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma

Lindsay S. Cooley, K. Bensalah, N. Rioux-Leclercq, 2021, Communications Biology.

Assessment of tumour‐associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma

B. Delahunt, H. Samaratunga, L. Egevad, 2018, Histopathology.

Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2017, World Journal of Urology.

BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma.

K. Bensalah, N. Rioux-Leclercq, P. Kapur, 2014, The Journal of urology.

Exercise training improves radiotherapy efficiency in a murine model of prostate cancer

N. Rioux-Leclercq, F. Paris, S. Chiavassa, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma

K. Bensalah, N. Rioux-Leclercq, P. Kapur, 2015, Cancer.

Does training of fellows affect peri‐operative outcomes of robot‐assisted partial nephrectomy?

K. Bensalah, N. Rioux-Leclercq, B. Peyronnet, 2017, BJU international.

Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease

N. Rioux-Leclercq, K. Dahan, E. Daugas, 2015, Medicine.

Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma

K. Bensalah, N. Rioux-Leclercq, E. Oger, 2014, BioMed research international.

Kidney Biopsy in Type 2 Diabetes: A Multicenter Cross-Sectional Study

N. Rioux-Leclercq, F. Vrtovsnik, D. Joly, 2021, American Journal of Nephrology.

Transperitoneal Laparoscopic Nephrectomy for Autosomal Dominant Polycystic Kidney Disease

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2012, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis

K. Bensalah, N. Rioux-Leclercq, S. Shariat, 2021, International Journal of Clinical Oncology.

Exploring Biological Predictive Factors of Progression After Surgery in High-Risk Renal Cell Carcinoma: Results From the French Cohort of the Randomized S-TRAC Trial Patients

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2020, Frontiers in Surgery.

Prognostic significance of the mode of detection in renal tumours

N. Rioux-Leclercq, F. Guillé, J. Patard, 2002, BJU international.

Expression screening of cancer/testis genes in prostate cancer identifies nr6a1 as a novel marker of disease progression and aggressiveness

N. Rioux-Leclercq, F. Guillé, M. Primig, 2013, The Prostate.

Identification of genital tract markers in the human seminal plasma using an integrative genomics approach.

C. Pineau, N. Rioux-Leclercq, J. Auger, 2013, Human reproduction.

The changing evolution of renal tumours: a single center experience over a two-decade period.

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2004, European urology.

Involvement of germline DDX1-MYCN duplication in inherited nephroblastoma.

N. Rioux-Leclercq, J. Andrieux, S. Odent, 2013, European journal of medical genetics.

Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.

N. Rioux-Leclercq, F. Bruyère, L. Doucet, 2017, Urologic oncology.

Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists

D. Berney, G. Kristiansen, J. Oxley, 2016, Journal of Clinical Pathology.

Slice correspondence estimation using SURF descriptors and context-based search for prostate whole-mount histology MRI registration

N. Rioux-Leclercq, O. Acosta, E. Romero, 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

N. Rioux-Leclercq, J. Patard, H. Wallerand, 2011, European urology.

Renal biopsies after 70 years of age: a retrospective longitudinal study from 2000 to 2007 on 150 patients in Western France.

N. Rioux-Leclercq, C. Vigneau, Émilie Pinçon, 2010, Archives of gerontology and geriatrics.

Stimulation of peripheral blood and intestinal mucosa cells by synthetic CpG oligodeoxynucleotides.

N. Rioux-Leclercq, P. d'Halluin, B. Birebent, 2004, Human immunology.

[Signalling pathways in renal-cell carcinoma: from the molecular biology to the future therapy].

N. Rioux-Leclercq, J. Patard, C. Vigneau, 2010, Bulletin du cancer.

[Renal cell carcinoma and prognostic factors].

N. Rioux-Leclercq, J. Edeline, 2008, Annales de pathologie.

Fatty acid profile in peri-prostatic adipose tissue and prostate cancer aggressiveness in African-Caribbean and Caucasian patients.

N. Rioux-Leclercq, F. Bruyère, L. Doucet, 2018, European journal of cancer.

Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use

N. Rioux-Leclercq, J. Patard, Anne-Sophie Thirouard, 2003, Cancer Immunology, Immunotherapy.

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study

N. Rioux-Leclercq, C. Sautès-Fridman, A. Desnoyer, 2022, Journal for ImmunoTherapy of Cancer.

[Impact of robotic assistance on the use and the outcomes of nephron-sparing surgery: A single center experience].

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Predictive factors of hemorrhagic complications after partial nephrectomy.

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis.

N. Rioux-Leclercq, F. Peale, G. Frantz, 2004, The Journal of clinical endocrinology and metabolism.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Porta, N. Rioux-Leclercq, A. Horwich, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[Treatment of metastatic kidney cancer in elderly subjects].

N. Rioux-Leclercq, J. Patard, H. Lang, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Comprehensive study of nine novel cases of TFEB‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression

K. Bensalah, N. Rioux-Leclercq, E. Compérat, 2022, Histopathology.

[Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer].

N. Rioux-Leclercq, J. Patard, H. Lang, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

MAGE‐A4, a germ cell specific marker, is expressed differentially in testicular tumors

P. Chomez, O. de Backer, N. Rioux-Leclercq, 2001, Cancer.

The Cancer-Testis Gene, NY-ESO-1, Is Expressed in Normal Fetal and Adult Testes and in Spermatocytic Seminomas and Testicular Carcinoma In Situ

N. Rioux-Leclercq, G. Jacobsen, B. Jégou, 2002, Laboratory Investigation.

An Anusual Cause of Secondary Hypertension in a Young Man

N. Rioux-Leclercq, C. Vigneau, B. Laguerre, 2015 .

Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2009, The Journal of urology.

Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years.

N. Rioux-Leclercq, J. Patard, F. Saint, 2001, Urology.

Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.

N. Rioux-Leclercq, F. Carrat, X. Mariette, 2016, Journal of the American Society of Nephrology : JASN.

Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.

N. Rioux-Leclercq, G. Bouzillé, N. Stock, 2017, Human pathology.

Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?

N. Rioux-Leclercq, J. Patard, S. Mottier, 2010, British Journal of Cancer.

Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2016, World Journal of Urology.

Anti-VEGF Therapy Induces Proteinuria through Endothelial Disorganization Leading to Nephrin Decrease in Podocytes

N. Rioux-Leclercq, C. Vigneau, M. Belaud‐Rotureau, 2015 .

Patient selection for laparoscopic excision of adrenal metastases: A multicenter cohort study.

K. Bensalah, N. Rioux-Leclercq, P. Caron, 2015, International journal of surgery.

[Adrenalectomy for adrenal metastases: is the laparoscopic approach beneficial for all patients?].

K. Bensalah, N. Rioux-Leclercq, B. Peyronnet, 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

HLA-G Is Widely Expressed by Mast Cells in Regions of Organ Fibrosis in the Liver, Lung and Kidney

N. Rioux-Leclercq, S. Jouneau, M. Samson, 2021, International Journal of Molecular Sciences.

Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization.

K. Bensalah, N. Rioux-Leclercq, S. Jaillard, 2019, Human pathology.

Independent association of PD‐L1 expression with noninactivated VHL clear cell renal cell carcinoma—A finding with therapeutic potential

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2017, International journal of cancer.

Prognostic Value of Fusobacterium nucleatum after Abdominoperineal Resection for Anal Squamous Cell Carcinoma

N. Rioux-Leclercq, S. Vacher, A. Lièvre, 2022, Cancers.

Does mechanical morcellation of large glands compromise incidental prostate cancer detection on specimen analysis? A pathological comparison with open simple prostatectomy

N. Rioux-Leclercq, E. Compérat, J. Guillotreau, 2018, World Journal of Urology.

[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer].

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Study of the expression of Aurora kinases in renal cell carcinoma].

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

N. Rioux-Leclercq, S. Terry, C. Sautès-Fridman, 2021, Clinical Cancer Research.

Disseminated infection caused by Sparganum proliferum in an AIDS patient

N. Rioux-Leclercq, P. Hofman, V. Hofman, 2010, Histopathology.

Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma.

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2018, Urologic oncology.

Prospective evaluation of a new rapid urease test (Pronto Dry) for the diagnosis of Helicobacter pylori infection.

N. Rioux-Leclercq, J. Bretagne, M. Ramée, 2004, Gastroenterologie clinique et biologique.

Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours.

N. Rioux-Leclercq, F. Guillé, J. Patard, 2002, European urology.

Renal cell carcinoma in children and adolescents: a retrospective study of a French–Italian series of 93 cases

N. Rioux-Leclercq, G. Malouf, G. Vujanić, 2022, Histopathology.

Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma.

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2022, European urology oncology.

[Oncologic and perioperative outcomes of robot-assisted radical cystectomy: A single-center prospective series].

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Long‐term Impact of Subclinical Inflammation Diagnosed by Protocol Biopsy One Year After Renal Transplantation

N. Rioux-Leclercq, E. Thervet, J. Goujon, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib

N. Rioux-Leclercq, D. Lambrechts, J. Zucman‐Rossi, 2020 .

Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases

N. Rioux-Leclercq, C. Magi-Galluzzi, A. Hartmann, 2018, Histopathology.

Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review.

Elisabeth Polard, Pierre Tattevin, Nathalie Rioux-Leclercq, 2018, International journal of antimicrobial agents.

VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants.

N. Rioux-Leclercq, P. Derreumaux, M. Delpech, 2017, Blood.

Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo

N. Rioux-Leclercq, B. Jégou, N. Dejucq-Rainsford, 2008, Retrovirology.

Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin β subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma

N. Rioux-Leclercq, P. Fergelot, C. Massart, 2005, Clinical chemistry and laboratory medicine.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

C. Porta, N. Rioux-Leclercq, A. Horwich, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunotherapy in Renal Cell Carcinoma: The Future Is Now

K. Bensalah, N. Rioux-Leclercq, B. Peyronnet, 2020, International journal of molecular sciences.

Immunopathology and Infectious Diseases Human Immunodeficiency Virus Infects Human Seminal Vesicles in Vitro and in Vivo

N. Rioux-Leclercq, B. Jégou, N. Dejucq-Rainsford, 2011 .

Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma.

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2012, Urologic oncology.

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.

N. Rioux-Leclercq, F. Guillé, J. Patard, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomics in upper tract urothelial carcinoma

K. Bensalah, N. Rioux-Leclercq, B. Peyronnet, 2017, Current opinion in urology.

Tissue cholesterol metabolism and prostate cancer aggressiveness: Ethno‐geographic variations

N. Rioux-Leclercq, F. Bruyère, M. Pinault, 2021, The Prostate.

Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus.

N. Rioux-Leclercq, F. Sutherland, J. Campion, 1999, Oncology reports.

A deep learning model trained on only eight whole-slide images accurately segments tumors: wise data use versus big data

N. Rioux-Leclercq, R. Bourgade, M. Griebel, 2022, bioRxiv.

Transcriptomic heterogeneity in multifocal prostate cancer.

M. Rubin, A. Chinnaiyan, N. Rioux-Leclercq, 2018, JCI insight.

Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting

N. Rioux-Leclercq, J. Patard, J. Zucman‐Rossi, 2015, Clinical Cancer Research.

Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.

B. Delahunt, A. Evans, J. Kench, 2019, Pathology.

Interleukin‐6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte–dendritic cell cross‐talk

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2006, Clinical and experimental immunology.

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas

C. Porta, N. Rioux-Leclercq, R. Schiappa, 2017, British Journal of Cancer.

Les tumeurs rénales: Recommandations de la conférence de consensus de I'International Society of Urologic Pathology (ISUP) 2012

J. Cheville, B. Delahunt, P. Humphrey, 2014 .

The experimental renal cell carcinoma model in the chick embryo

N. Rioux-Leclercq, J. Patard, A. Ravaud, 2012, Angiogenesis.

Prognostic Value of PD‐1 and PD‐L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2017, The Journal of urology.

Non-Clear Cell Renal Cell Carcinomas: From Shadow to Light.

N. Rioux-Leclercq, T. Choueiri, R. Flippot, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human immunodeficiency virus infects human seminal vesicles in vitro and in vivo.

N. Rioux-Leclercq, B. Jégou, N. Dejucq-Rainsford, 2011, The American journal of pathology.

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma

N. Rioux-Leclercq, J. Pouysségur, N. Mazure, 2018, PloS one.

MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array

N. Rioux-Leclercq, J. Patard, J. Bernhard, 2014, Clinical Cancer Research.

Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors.

N. Rioux-Leclercq, J. Zucman‐Rossi, C. Sautès-Fridman, 2019, Clinical genitourinary cancer.

Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma

K. Bensalah, N. Rioux-Leclercq, R. Mathieu, 2019, International journal of molecular sciences.

Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting

N. Rioux-Leclercq, J. Zucman‐Rossi, E. Lerut, 2017, Clinical genitourinary cancer.

Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases

K. Bensalah, N. Rioux-Leclercq, A. Lespagnol, 2017, Virchows Archiv.

Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas

N. Rioux-Leclercq, J. Bernhard, C. Creighton, 2016, Scientific Reports.

Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up.

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2016, European urology focus.

Prognostic value of thrombocytosis in renal cell carcinoma.

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2006, The Journal of urology.

Bone metastasis is associated with poor prognosis in metastatic papillary renal cell carcinoma patients treated with first agent angiogenesis inhibitors.

N. Rioux-Leclercq, M. Baldewijns, E. Lerut, 2020, Urologic oncology.

Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial.

N. Rioux-Leclercq, A. Ravaud, B. Escudier, 2020, European journal of cancer.

Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients.

K. Bensalah, N. Rioux-Leclercq, A. Lardenois, 2023, European urology.

Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2015, Urologic oncology.

Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).

N. Rioux-Leclercq, F. Goldwasser, B. Escudier, 2021, European journal of cancer.

Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.

N. Rioux-Leclercq, J. Bansard, J. Moulinoux, 2000, Urology.

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2008, International journal of cancer.

Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression.

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2019, Clinical genitourinary cancer.

Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2012, Human pathology.

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2009, British Journal of Cancer.

Understanding the importance of smart drugs in renal cell carcinoma.

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2006, European urology.

Renal Tumors: Diagnostic and Prognostic Biomarkers

B. Delahunt, D. Grignon, J. Srigley, 2013, The American journal of surgical pathology.

Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas.

K. Bensalah, N. Rioux-Leclercq, E. Oger, 2013, Human pathology.

A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.

N. Rioux-Leclercq, F. Guillé, J. Patard, 2007, The Journal of urology.

Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

N. Rioux-Leclercq, F. Guillé, J. Patard, 2005 .

Loss of expression of TIMP3 in clear cell renal cell carcinoma.

Damien Masson, Nathalie Rioux-Leclercq, Jean-Jacques Patard, 2010, European journal of cancer.

Determination of Angptl4 mRNA as a Diagnostic Marker of Primary and Metastatic Clear Cell Renal-Cell Carcinoma

Sophie Ferlicot, Hany Soliman, Nathalie Rioux-Leclercq, 2010, PloS one.

Squamous cell carcinoma arising in a hepatic forgut cyst.

N. Rioux-Leclercq, K. Boudjema, Y. Gandon, 2002, Pathology, research and practice.

Colistin-containing cement spacer for treatment of experimental carbapenemase-producing Klebsiella pneumoniae prosthetic joint infection.

N. Rioux-Leclercq, I. Ghout, P. Tattevin, 2019, International journal of antimicrobial agents.

Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients. Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations.

N. Rioux-Leclercq, H. Léna, Sarah Medane, 2017, Oncotarget.

Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines

N. Rioux-Leclercq, J. Patard, E. Oger, 2012, Journal of Cancer Research and Clinical Oncology.

MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer.

N. Rioux-Leclercq, F. Beuvon, A. Lièvre, 2022, Clinics and research in hepatology and gastroenterology.

Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma.

N. Rioux-Leclercq, F. Guillé, J. Patard, 2003, European urology.

Recommandations en Onco-Urologie 2010 : Cancer du rein

N. Rioux-Leclercq, J. Patard, H. Lang, 2010 .

Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2012, The Journal of urology.

Solitary Contralateral Adrenal Metastasis after Nephrectomy for Renal Cell Carcinoma

N. Rioux-Leclercq, B. Lobel, S. Moudouni, 2002, Urologia Internationalis.

[Importance of the macroscopic examination and histologic report in the therapeutic management of kidney tumors].

N. Rioux-Leclercq, 2009, Annales de pathologie.

Prognostic ability of simplified nuclear grading of renal cell carcinoma

N. Rioux-Leclercq, J. Patard, P. Karakiewicz, 2007, Cancer.

[Clinical and histological prognostic factors of renal cancer with caval thrombus].

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2004, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.

N. Rioux-Leclercq, J. Patard, J. Epstein, 2001, Human pathology.

N. Rioux-Leclercq, E. Thervet, C. Vigneau, 2017, Clinical kidney journal.

Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage

N. Rioux-Leclercq, M. Dimanche-Boitrel, D. Lagadic-Gossmann, 2008, Oncogene.

Renal Dysfunction in Patients With Direct Infiltration by B-Cell Lymphoma

R. Houot, N. Rioux-Leclercq, O. Decaux, 2019, Kidney international reports.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Porta, N. Rioux-Leclercq, A. Horwich, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Renal cell carcinoma with leiomyomatous stroma in tuberous sclerosis complex: a distinct entity

K. Bensalah, N. Rioux-Leclercq, B. Peyronnet, 2020, Virchows Archiv.

Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review.

N. Rioux-Leclercq, E. Compérat, O. Hes, 2016, Annals of diagnostic pathology.

The experimental renal cell carcinoma model in the chick embryo

N. Rioux-Leclercq, J. Patard, A. Ravaud, 2012, Angiogenesis.

The Application of Artificial Intelligence in Prostate Cancer Management—What Improvements Can Be Expected? A Systematic Review

Thomas Darde, Shahrokh F. Shariat, Karim Bensalah, 2020, Applied Sciences.

Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy

K. Bensalah, N. Rioux-Leclercq, V. Margulis, 2016, World Journal of Urology.

PPARγ is functionally expressed in clear cell renal cell carcinoma.

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2011, International journal of oncology.

Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases.

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2007, Human pathology.

Place du pathologiste dans la prise en charge du carcinome rénal en situation néoadjuvante

N. Rioux-Leclercq, X. Leroy, J. Edeline, 2011 .

[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].

N. Rioux-Leclercq, J. Patard, S. Théoleyre, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma.

N. Rioux-Leclercq, F. Guillé, J. Patard, 2004, Human pathology.

Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney.

N. Rioux-Leclercq, J. Epstein, 2009, Archives of pathology & laboratory medicine.

[Breast carcinoma metastasis into a renal cell carcinoma].

N. Rioux-Leclercq, P. Kerbrat, D. Chiforeanu, 2011, Annales de pathologie.

Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer

N. Rioux-Leclercq, Patrick Legembre, A. Fautrel, 2019, Molecular Cancer Research.

A novel mechanism of HIF2-dependent PLK1-mediated metastasis and drug resistance of clear cell Renal Cell Carcinoma

Lindsay S. Cooley, K. Bensalah, N. Rioux-Leclercq, 2020 .

[Composite pheochromocytoma: A rare adrenal tumor].

N. Rioux-Leclercq, F. Tissier, B. Peyronnet, 2017, Annales de pathologie.

[Unusual variety of bladder urothelial carcinoma: "nest type" microlobular carcinoma: report of an anatomoclinical case and review of the literature].

N. Rioux-Leclercq, C. Billerey, B. Lobel, 2000, Annales d'urologie.

New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis.

N. Rioux-Leclercq, D. Samuel, F. Paraf, 2020, Kidney international.

Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis.

N. Rioux-Leclercq, J. Patard, S. Culine, 2008, Clinical Chemistry.

Molecular basis for a novel systemic form of human hereditary apoA-I amyloidosis with vision loss

J. Straub, N. Rioux-Leclercq, F. Paraf, 2018, bioRxiv.

Safety and Feasibility of Laparoscopic Nephrectomy for Big Tumors (≥ 10 cm): A Retrospective Multicentric Study.

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2016, Clinical genitourinary cancer.

[The laparoscopic nephrectomy for polycystic kidney is feasible and reproducible].

K. Bensalah, N. Rioux-Leclercq, C. Vigneau, 2013, Progrès en urologie (Paris).

Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2014, World Journal of Urology.

Laparoscopic management of a transitional cell carcinoma arising in a right ectopic ureter

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2006, International journal of urology : official journal of the Japanese Urological Association.

Does tumour effraction during robotic partial nephrectomy have any impact on recurrence?

K. Bensalah, N. Rioux-Leclercq, A. Goujon, 2018, International Journal of Clinical Oncology.

Predicting morbidity after robotic partial nephrectomy: The effect of tumor, environment, and patient-related factors.

K. Bensalah, N. Rioux-Leclercq, J. Raman, 2018, Urologic oncology.

Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2010, European urology.

[The place of laparoscopic nephrectomy in the elderly subject].

N. Rioux-Leclercq, J. Patard, H. Lang, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[CCAFU french national guidelines 2016-2018 on renal cancer].

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

What Is Better for Predicting Morbidity of Robotic Partial Nephrectomy-A Score or Your Clinical Judgement?

K. Bensalah, N. Rioux-Leclercq, S. Shariat, 2020, European urology focus.

[CCAFU Recommendations 2013: Renal cancer].

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Renal toxicity of anti-VEGF (corrected) targeted therapies].

N. Rioux-Leclercq, C. Vigneau, 2013, Nephrologie & therapeutique.

Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review

N. Rioux-Leclercq, B. Peyronnet, C. Brochard, 2018, Neurourology and urodynamics.

Three kidneys, two diseases, one antibody?

N. Rioux-Leclercq, C. Vigneau, Nolwenn Lorcy, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Specificities of small cell neuroendocrine prostate cancer: Adverse prognostic value of TTF1 expression.

N. Rioux-Leclercq, F. Bruyère, F. Rozet, 2020, Urologic oncology.

Collecting duct renal cell carcinoma: a matched analysis of 41 cases.

N. Rioux-Leclercq, J. Patard, A. Valéri, 2007, European urology.

Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.

K. Bensalah, N. Rioux-Leclercq, F. Montorsi, 2014, European urology.

[Cytogenetics profiles of renal carcinoma].

K. Bensalah, N. Rioux-Leclercq, C. Vigneau, 2014, Morphologie : bulletin de l'Association des anatomistes.

Accuracy of preoperative imaging methods in a retrospective series of 14 patients with operated intraductal papillary mucinous tumors of the pancreas.

N. Rioux-Leclercq, B. Meunier, D. Olivié, 2005, Gastroenterologie clinique et biologique.

Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target

Karl J. Dykema, N. Rioux-Leclercq, J. Patard, 2012, The Journal of pathology.

Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting

A. Masson-Lecomte, K. Bensalah, N. Rioux-Leclercq, 2017, World Journal of Urology.

Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study

K. Bensalah, N. Rioux-Leclercq, A. Lespagnol, 2021, Journal of Clinical Pathology.

[Do ablative treatments modify the management of kidney tumors in the elderly?].

N. Rioux-Leclercq, J. Patard, H. Lang, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2021, Urologia Internationalis.

[A case of idiopathic myointimal hyperplasia of mesenteric veins].

N. Rioux-Leclercq, G. Bouguen, S. Hénno, 2016, Annales de pathologie.

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

N. Rioux-Leclercq, G. Pagès, P. Lenormand, 2019, Theranostics.

Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.

K. Bensalah, N. Rioux-Leclercq, P. Fergelot, 2014, Human pathology.

[French ccAFU guidelines - update 2020-2022: management of kidney cancer].

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

N. Rioux-Leclercq, G. Pagès, J. Iovanna, 2020, Oncoimmunology.

Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2015, The Journal of urology.

PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2019, Urologic oncology.

Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study

K. Bensalah, N. Rioux-Leclercq, Y. Lotan, 2019, World Journal of Urology.

Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.

K. Bensalah, N. Rioux-Leclercq, S. Crouzet, 2020, European urology focus.

Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2016, International journal of urology : official journal of the Japanese Urological Association.

Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study)

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2018, World Journal of Urology.

[Renin-angiotensin system and urological cancers].

K. Bensalah, N. Rioux-Leclercq, C. Vigneau, 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma.

N. Rioux-Leclercq, J. Epstein, D. Chan, 2002, Urology.

Artificial Intelligence-Based Opportunities in Liver Pathology—A Systematic Review

N. Rioux-Leclercq, J. Calderaro, O. Acosta, 2023, Diagnostics.

[Optical spectroscopy: a new approach to assess urological tumors].

L. Senhadji, J. Fleureau, K. Bensalah, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classification

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2019, International Urology and Nephrology.

Use of 5α‐reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population‐based study

N. Rioux-Leclercq, E. Oger, E. Nowak, 2018, BJU international.

The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma.

N. Rioux-Leclercq, J. Patard, P. Karakiewicz, 2010, European journal of cancer.

Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept

K. Bensalah, N. Rioux-Leclercq, S. Shariat, 2020, World Journal of Urology.

Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma

N. Rioux-Leclercq, J. Patard, J. Zucman‐Rossi, 2017, Acta oncologica.

Towards a Reduced In Silico Model Predicting Biochemical Recurrence After Radiotherapy in Prostate Cancer

Oscar Acosta, Alain Fautrel, Renaud de Crevoisier, 2021, IEEE Transactions on Biomedical Engineering.

Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients: Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations

N. Rioux-Leclercq, H. Léna, Sarah Medane, 2017, Oncotarget.

Voluntary Wheel Running Does Not Enhance Radiotherapy Efficiency in a Preclinical Model of Prostate Cancer: The Importance of Physical Activity Modalities?

N. Rioux-Leclercq, J. Escoffre, B. Denis de Senneville, 2021, Cancers.

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5

N. Rioux-Leclercq, G. Pagès, V. Imbert, 2019, Theranostics.

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2018, Theranostics.

Soluble CD 146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2018 .

Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma.

B. Delahunt, H. Samaratunga, M. Varma, 2019, Pathology.

Évaluation prospective d ’ un nouveau test rapide à l ’ uréase ( Pronto Dry T ) pour le diagnostic d ’ infection à Helicobacter pylori

N. Rioux-Leclercq, J. Bretagne, M. Ramée, 2004 .

[Molecular pathways of tumour angiogenesis and new targeted therapeutic approaches in renal cancer].

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2005, Progrès en urologie (Paris).

NIVOREN GETUG-AFU 26 translational study: Association of PD-1, AXL, and PBRM-1 with outcomes in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N).

N. Rioux-Leclercq, C. Sautès-Fridman, N. Chaput, 2020 .

[A rare paratesticular tumor].

N. Rioux-Leclercq, R. Mathieu, T. Fardoun, 2017, Annales de pathologie.

[Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations].

J. Cheville, B. Delahunt, D. Grignon, 2014, Annales de pathologie.

Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.

N. Rioux-Leclercq, J. Patard, J. Bansard, 2000, European Cytokine Network.

Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.

N. Rioux-Leclercq, J. Patard, A. Villers, 2010, Urology.

The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.

N. Rioux-Leclercq, J. Patard, P. Karakiewicz, 2010, The Journal of urology.

The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13.

N. Rioux-Leclercq, E. Darrigrand, X. Le Goff, 2017, Oncotarget.

Synchronous Metastatic Clear‐Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype

K. Bensalah, N. Rioux-Leclercq, J. Mosser, 2017, Clinical genitourinary cancer.

[Multinodular-adenomatoid tumor of the uterus in a patient with a renal allograft].

N. Rioux-Leclercq, E. Bauville, F. Burtin, 2008, Annales de Pathologie.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Porta, N. Rioux-Leclercq, J. Patard, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Drug-Induced Acute Interstitial Nephritis with Nifedipine

N. Rioux-Leclercq, C. Vigneau, Nolwenn Lorcy, 2016, Case Reports in Nephrology.

Acute and chronic nephropathy induced by fluindione must be addressed.

N. Rioux-Leclercq, P. Le Cacheux, C. Vigneau, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial

N. Rioux-Leclercq, Y. Allory, M. Colombel, 2023, World journal of urology.

PDL-1 and PDL1 expressions in clear cell renal cell carcinoma (ccRCC) of metastatic patients with sunitinib first-line treatment.

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2015 .

Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review

K. Bensalah, N. Rioux-Leclercq, O. Acosta, 2023, Diagnostics.

Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaboration.

A. Sangoi, N. Rioux-Leclercq, A. Chou, 2023, Human pathology.

[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer].

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Can Molecular Classifications Help Tailor First-line Treatment of Metastatic Renal Cell Carcinoma? A Systematic Review of Available Models

K. Bensalah, N. Rioux-Leclercq, I. Ouzaid, 2022, European urology open science.

Tumor molecular characteristics in patients (pts) with international metastatic renal cell carcinoma database consortium (IMDC) good (G) and intermediate/poor (I/P) risk.

N. Rioux-Leclercq, J. Zucman‐Rossi, E. Lerut, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2014, Clinical genitourinary cancer.

Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study.

K. Bensalah, N. Rioux-Leclercq, J. Bernhard, 2014, Urologic oncology.

Rationale and design of the CANARI study: a case–control study investigating the association between prostate cancer and 5‐alpha‐reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific region in France

N. Rioux-Leclercq, E. Nowak, S. Vincendeau, 2018, Fundamental & clinical pharmacology.

Anti-glomerular basement membrane disease , ulcerative colitis , and primary sclerosing cholangitis : link or coincidence ?

N. Rioux-Leclercq, G. Bouguen, G. Coiffier, 2019 .

Anti-glomerular basement membrane disease, ulcerative colitis, and primary sclerosing cholangitis: link or co-incidence

N. Rioux-Leclercq, G. Bouguen, G. Coiffier, 2010 .

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment.

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2017, Urologic oncology.

[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer].

N. Rioux-Leclercq, J. Bernhard, J. Hétet, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer].

N. Rioux-Leclercq, J. Bernhard, J. Hétet, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Rare renal tumors. Case no 6. Renal metastases].

N. Rioux-Leclercq, 2014, Annales de Pathologie.

[Renin-angiotensin system and urological cancers].

K. Bensalah, N. Rioux-Leclercq, T. Dolley-Hitze, 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Expression screening of cancer/testis genes in prostate cancer identifies nr6a1 as a novel marker of disease progression and aggressiveness

N. Rioux-Leclercq, F. Guillé, M. Primig, 2013, The Prostate.

Transcriptomic heterogeneity in multifocal prostate cancer.

M. Rubin, A. Chinnaiyan, N. Rioux-Leclercq, 2018, JCI insight.

Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.

N. Rioux-Leclercq, G. Bouzillé, N. Stock, 2017, Human pathology.

[Lysozyme-induced nephropathy: A rare cause of renal failure in chronic myelomonocytic leukemia].

N. Rioux-Leclercq, N. Rioux-Leclercq, T. Frouget, 2020, Annales de pathologie.

The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.

François Guillé, Nathalie Rioux-Leclercq, Jean-Jacques Patard, 2005, Human pathology.

The Application of Artiﬁcial Intelligence in Prostate Cancer Management—What Improvements Can Be Expected? A Systematic Review

N. Rioux-Leclercq, B. Peyronnet, Z. Khene, 2022 .

[Secondary tumors localized in testis].

K. Bensalah, N. Rioux-Leclercq, B. Peyronnet, 2023, Annales de pathologie.

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

N. Rioux-Leclercq, J. Patard, P. Fergelot, 2008, International journal of cancer.

Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : prise en charge du cancer du rein

N. Rioux-Leclercq, I. Ouzaid, J. Correas, 2020, Progrès en Urologie.

[CCAFU Recommendations 2013: Penile cancer].

N. Rioux-Leclercq, J. Patard, P. Paparel, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.